Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $90.49 -0.04%
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Join SI Premium – FREE
Goldman Sachs analyst David Roman lowered the price target on Abbott Labs (NYSE: ABT) to $121.00 (from $140.00) while maintaining a Conviction Buy rating.
You May Also Be Interested In
- Piper Sandler on Abbott Labs (ABT): 'A Name Worth Revisiting'
- New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
- Syngene International Ltd (SYNG:IN) PT Lowered to INR735 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
